» Articles » PMID: 15569893

Anxiety Disorder Comorbidity in Bipolar Disorder Patients: Data from the First 500 Participants in the Systematic Treatment Enhancement Program for Bipolar Disorder (STEP-BD)

Overview
Journal Am J Psychiatry
Specialty Psychiatry
Date 2004 Dec 1
PMID 15569893
Citations 155
Authors
Affiliations
Soon will be listed here.
Abstract

Objective: The authors provide a detailed perspective on the correlates of comorbid anxiety in a large, well-characterized sample of bipolar disorder patients.

Method: Anxiety and its correlates were examined in a cross-sectional sample from the first 500 patients with bipolar I or bipolar II disorder enrolled in the Systematic Treatment Enhancement Program for Bipolar Disorder, a multicenter project funded by the National Institute of Mental Health designed to evaluate the longitudinal outcome of patients with bipolar disorder.

Results: Lifetime comorbid anxiety disorders were common, occurring in over one-half of the sample, and were associated with younger age at onset, decreased likelihood of recovery, poorer role functioning and quality of life, less time euthymic, and greater likelihood of suicide attempts. Although substance abuse disorders were particularly prevalent among patients with anxiety disorders, comorbid anxiety appeared to exert an independent, deleterious effect on functioning, including history of suicide attempts (odds ratio=2.45, 95% CI=1.4-4.2).

Conclusions: An independent association of comorbid anxiety with greater severity and impairment in bipolar disorder patients was demonstrated, highlighting the need for greater clinical attention to anxiety in this population, particularly for enhanced clinical monitoring of suicidality. In addition, it is important to determine whether effective treatment of anxiety symptoms can lessen bipolar disorder severity, improve response to treatment of manic or depressive symptoms, or reduce suicidality.

Citing Articles

Untangling the complex relationship between bipolar disorder and anxiety: a comprehensive review of prevalence, prognosis, and therapy.

Wang Y, Liu J, Zhang R, Luo G, Sun D J Neural Transm (Vienna). 2025; 132(4):567-578.

PMID: 39755917 DOI: 10.1007/s00702-024-02876-x.


The Impact on Anxiety Symptoms of an Immersive Virtual Reality Remediation Program in Bipolar Disorders: A Randomized Clinical Trial.

Primavera D, Urban A, Cantone E, Nonnis M, Gonzalez C, Perra A J Clin Med. 2024; 13(14).

PMID: 39064243 PMC: 11277986. DOI: 10.3390/jcm13144203.


Cognition in Euthymic Patients with Bipolar Disorder: Do Not Forget to Account for Anxiety!.

Yoldi-Negrete M, Fresan A, Jimenez-Rodriguez L, Tirado-Duran E Neuropsychiatr Dis Treat. 2024; 20:1181-1189.

PMID: 38855382 PMC: 11162183. DOI: 10.2147/NDT.S457186.


Effect of locosamide as an add-on therapy in the management of dissociative disorders.

Prasad S, Verma A, Kumar S, Gupta S Bioinformation. 2024; 20(4):373-377.

PMID: 38854771 PMC: 11161883. DOI: 10.6026/973206300200373.


Obsessive-Compulsive Disorder as an Epiphenomenon of Comorbid Bipolar Disorder? An Updated Systematic Review.

de Filippis R, Aguglia A, Costanza A, Benatti B, Placenti V, Vai E J Clin Med. 2024; 13(5).

PMID: 38592113 PMC: 10931838. DOI: 10.3390/jcm13051230.